Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) has issued an update.
Shanghai Bio-heart Biological Technology Co., Ltd. announced a voluntary update regarding its proposal to repurchase and cancel H shares as part of its 2022 H Share Incentive Scheme. The company received a waiver from compliance with certain requirements of the Share Buy-backs Code for this off-market share buy-back, which is subject to shareholder approval at the upcoming annual general meeting. Stakeholders are advised to exercise caution when dealing with the company’s shares.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of innovative biological products. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange, with a primary market focus on biological technology advancements.
Average Trading Volume: 280,408
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.09B
For an in-depth examination of 2185 stock, go to TipRanks’ Stock Analysis page.